Approval · Notice of Compliance 1868 · 1999
WELLFERON: Notice of Compliance 1868
Issued April 20, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1868
- Date
- April 20, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in manufacturing - new master cell bank - new manufacturing facility
- Therapeutic class
- Biological response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| WELLFERON | Not yet assigned | — |
Medicinal ingredients
- INTERFERON ALPHA-N1 (INS) 3,000,000 UNIT per ML
- INTERFERON ALPHA-N1 (INS) 5,000,000 UNIT per ML
- INTERFERON ALPHA-N1 (INS) 10,000,000 UNIT per ML